These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
4. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005 [TBL] [Abstract][Full Text] [Related]
5. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267 [TBL] [Abstract][Full Text] [Related]
6. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Fishman DA; Bafetti LM; Stack MS Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550 [TBL] [Abstract][Full Text] [Related]
7. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652 [TBL] [Abstract][Full Text] [Related]
8. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. Jones JL; Glynn P; Walker RA J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569 [TBL] [Abstract][Full Text] [Related]
9. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]. Zhou CY; Yao JF; Chen XD Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097 [TBL] [Abstract][Full Text] [Related]
10. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential. Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells. Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327 [TBL] [Abstract][Full Text] [Related]
12. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas]. Li L; Zhang S; Lin H; Lin JY Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells. Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Ohashi K; Nemoto T; Nakamura K; Nemori R Cancer; 2000 May; 88(10):2201-9. PubMed ID: 10820340 [TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079 [TBL] [Abstract][Full Text] [Related]
16. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Shiomi T; Okada Y Cancer Metastasis Rev; 2003; 22(2-3):145-52. PubMed ID: 12784993 [TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis. Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells. Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378 [TBL] [Abstract][Full Text] [Related]
20. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]